<DOC>
	<DOCNO>NCT01699477</DOCNO>
	<brief_summary>The aim study asses efficacy clinical safety transcranial magnetic resonance guide high intensity focus ultrasound system ExAblate 4000 , InSightec Ltd. functional neurosurgery . The treatment conduct study non-invasive , i.e . without open skull , create micro-thalamotomies specific target area thalamus , subthalamus pallidum . The data obtain study use evaluate basic safety aspects new treatment technology serve basis clinical introduction MR-guided ultrasound-neurosurgery .</brief_summary>
	<brief_title>Safety Study Using Transcranial MR Guided Focused Ultrasound Treatment Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<criteria>1 . Male female patient 18 year old 2 . Clinical indication medial thalamotomy 3 . Stereotactic target within thalamus , subthalamus pallidum 4 . All target supposedly accessible TcMRgFUS 5 . Physically mentally able understand risk participate study give write informed consent base patient information provide 6 . Sufficient proficiency one languages German , French , Italian English allow verbal communication phase study 7 . Physically mentally able communicate personal condition feeling TcMRgFUS treatment 8 . Physically mentally able undergo TcMRgFUS treatment 1 . Anomalies brain anatomy , especially around thalamus pallidum influence atlasbased navigation 2 . Existing lesion close proximity ( &lt; 5mm ) plan ablation target 3 . Extended anomaly scalp scar , inflammation , etc . 4 . Clips implant object close ( &lt; 3cm ) target 5 . NonMRIcompatible cardiac pacemaker 6 . Previous hemorrhage brain 7 . Uncontrolled arterial hypertension 8 . Any coagulopathy patient anticoagulant therapy 9 . Sensitivity MRI contrast agent 10 . Contraindications MRI nonMRIcompatible implant device 11 . Large patient fit comfortably MRI unit ( generally &gt; 110kg ) 12 . Difficulty lie supine still 4 hour MRI unit claustrophobia 13 . Other known lifethreatening systemic disease 14 . Patients currently participate participate another clinical trial last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>FUS</keyword>
	<keyword>focus ultrasound</keyword>
	<keyword>functional brain disorder</keyword>
	<keyword>neuropathic pain</keyword>
	<keyword>movement disorder</keyword>
</DOC>